Skip to main content

Find Clinical Trials

Home
Conditions
Leishmaniasis

Clinical trial condition

Leishmaniasis

Explore clinical trials studying Leishmaniasis. Study availability and eligibility vary by location and protocol.

56 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Leishmaniasis trial results

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

NCT00111553

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +8 more
Locations: Universidade Federal de Minas Gerais Belo Horizonte, Minas Gerais, Brazil

Ambulatório de Leishmanioses da Secretaria Municipal da Saude de Januária Januária, Minas Gerais, Brazil

View Trial Details

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

NCT00111514

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +9 more
Locations: Clínica de Leishmaniasis, Hospital Nacional Sur Este EsSalud Cusco, Peru

Universidad Peruana Cayetano Heredia Lima, Peru

View Trial Details

Completed

Miltefosine for Mucosal Leishmaniasis

NCT00373776

Conditions: Euglenozoa Infections, Infections, Leishmaniasis, +7 more
Locations: Palos Blancos, Bolivia

View Trial Details

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

NCT00121862

Conditions: Cutaneous Leishmaniasis, Euglenozoa Infections, Infections, +9 more
Locations: Programa de Estudio y Control de Enfermedades Tropicales (PECET) Medellín, Colombia

View Trial Details

Completed

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

NCT00121849

Conditions: Cutaneous Leishmaniasis, Euglenozoa Infections, Infections, +9 more
Locations: Programa de Estudio y Control de Enfermedades Tropicales (PECET) Medellín, Colombia

View Trial Details

Completed

Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil

NCT00004755

Conditions: Communicable Diseases, Disease Attributes, Euglenozoa Infections, +13 more
Locations: Not specified

View Trial Details